Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast

Nuclear Medicine Communications

Volumn 32, Issue 11, 2011, Pages 1084-1087

  Usmani, Sharjeel ^a   Khan, Haider Ali ^a   Saleh, Noha Al ^a   Huda, Fawaz Abu ^a   Marafi, Fahad ^a   Amanguno, Henney G ^a   Nafisi, Naheel Al ^a   Kandari, Farida Al ^a  

^a Hussain Makki Al Jumma Centre for Specialized Surgery HMJCSS   (Kuwait)

Author keywords

ductal carcinoma in situ; lymphoscintigraphy; sentinel lymph node

Indexed keywords

NANOCOLLOID TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOSCINTIGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 80053575449     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328349eafc     Document Type: Article

References (32)

1. Ersnter VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002; 94:1546-1554. (Pubitemid 35277278)
2. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004; 350:1430-1441. (Pubitemid 38419997)
3. Baxter NN, Virnig BA, Dirham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004; 96:443-448. (Pubitemid 38443647)
4. Silverstein MJ, Gierson ED, Colburn WJ, Rosser RJ, Weisman JR, Gamagami P. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynaecol Obst 1991; 172:211-214.
5. Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, et al. Outcomes for women with ductal carcinoma-in situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol 2007; 14:2911-2917. (Pubitemid 47460624)
6. Yen WF, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200:516-526. (Pubitemid 40432319)
7. Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, et al.; Consensus Conference Committee. Consensus conference on breast conservation, Milan, Italy, 28 April-1 May 2005. Breast J 2006; 12:398-407.
8. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-7720. (Pubitemid 46291835)
9. De Cicco C, Trifiro G, Intra M, Marotta G, Ciprian A, Frasson A, et al. Optimised nuclear medicine method for tumor marking and sentinel node detection in occult primary breast lesions. Eur J Med Mol Imaging 2004; 31:349-354. (Pubitemid 38314078)
10. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001; 67:513-521.
11. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000; 7:15-20. (Pubitemid 30078488)
12. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-5553.
13. Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol 2007; 25:3664-3669. (Pubitemid 47372605)
14. Nieweg OE, Van Rijk MC, Valdes Olmos RA, Hoefnagel CA. Sentinel node biopsy and selective lymph node clearance impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging 2005; 32:631-634. (Pubitemid 40897483)
15. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247:207-213. (Pubitemid 351156760)
16. Bonnett M, Wallis T, Rossmann M, Pernick NL, Carolin KA, Segel M, et al. Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy. Mod Pathol 2002; 15: 95-101. (Pubitemid 34171318)
17. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86:429-438. (Pubitemid 29347405)
18. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005; 35:116-128. (Pubitemid 40568744)
19. Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H. Risk factors for lymph node metastases in breast carcinoma in situ with minimal invasive component. Arch Surg 2002; 137:1249-1252. (Pubitemid 35345896)
20. Frykberg ER, Bland KI. In-situ breast carcinoma. Adv Surg 1993; 26:29-72.
21. Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg 2006; 192:455-457. (Pubitemid 44344181)
22. Rubio IT, Roca I, Sabadell D, Xercavins J. Benefit of sentinel node biopsy in patients with breast ductal carcinoma in situ. Cir Esp 2009; 85:92-95.
23. Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg 2008; 95:547-554.
24. Klauber-De More N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Ann Surg Oncol 2000; 7:636-642.
25. Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ. A more aggressive disease? Arch Surg 2003; 138:537-540. (Pubitemid 36542469)
26. Silverstein MJ. Ductal carcinoma in situ with microinvasion. In: Silverstein MJ, editor. Ductal carcinoma in situ of breast 1997; Baltimore: Williams & Wilkins. pp. 557-562.
27. Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol 2009; 35:43-47.
28. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sacchini V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003; 138:309-313. (Pubitemid 36292666)
29. Lee CH, Carter D, Philpotts LE, Couce ME, Horvath LJ, Lange RC, Tocino I. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy. Can invasion be predicted? Radiology 2000; 217:466-470.
30. Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, et al. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Breast J 2008; 14:135-140. (Pubitemid 351341834)
31. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001; 8:275-277. (Pubitemid 32422851)
32. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-7720. (Pubitemid 46291835)